000			01969 a2200529 4500
005			20250517053944.0
264		0	_c20161006
008			201610s 0 0 eng d
022			_a1544-3450
024	7		_a10.1331/JAPhA.2015.15017 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoaddeb, Jivan
245	0	0	_aCommunity pharmacists' experience with pharmacogenetic testing. _h[electronic resource]
260			_bJournal of the American Pharmacists Association : JAPhA _c
300			_a587-594 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAttitude of Health Personnel
650	0	4	_aClopidogrel
650	0	4	_aCommunication
650	0	4	_aCommunity Pharmacy Services
650	0	4	_aCytochrome P-450 CYP2C19 _xgenetics
650	0	4	_aFeasibility Studies
650	0	4	_aGenetic Testing
650	0	4	_aGenotype
650	0	4	_aHealth Knowledge, Attitudes, Practice
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage
650	0	4	_aLiver-Specific Organic Anion Transporter 1
650	0	4	_aNorth Carolina
650	0	4	_aOrganic Anion Transporters _xgenetics
650	0	4	_aPatient Acceptance of Health Care
650	0	4	_aPharmacists
650	0	4	_aPharmacogenetics
650	0	4	_aPhenotype
650	0	4	_aPlatelet Aggregation Inhibitors _xadministration & dosage
650	0	4	_aPredictive Value of Tests
650	0	4	_aProfessional Role
650	0	4	_aProfessional-Patient Relations
650	0	4	_aProgram Evaluation
650	0	4	_aSimvastatin _xadministration & dosage
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTiclopidine _xadministration & dosage
700	1		_aMills, Rachel
700	1		_aHaga, Susanne B
773	0		_tJournal of the American Pharmacists Association : JAPhA _gvol. 55 _gno. 6 _gp. 587-594
856	4	0	_uhttps://doi.org/10.1331/JAPhA.2015.15017 _zAvailable from publisher's website
999			_c25298412 _d25298412